Lemaitre Vascular (LMAT) EBIT Growth (3y) (2013 - 2026)
Powered by 
Analysis
Lemaitre Vascular (LMAT) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 13.06% |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn | 29.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.23% |
| Mar 31, 2026 | 31.18% |
| Dec 31, 2025 | 39.30% |
| Sep 30, 2025 | 48.92% |
| Jun 30, 2025 | 40.79% |
| Mar 31, 2025 | 16.78% |
| Dec 31, 2024 | 15.69% |
| Sep 30, 2024 | 13.16% |
| Jun 30, 2024 | 8.99% |
| Mar 31, 2024 | 14.33% |
| Dec 31, 2023 | 2.26% |
| Sep 30, 2023 | -2.87% |
| Jun 30, 2023 | 24.72% |
| Mar 31, 2023 | 21.84% |
| Dec 31, 2022 | 12.23% |
| Sep 30, 2022 | 1.36% |
| Jun 30, 2022 | -0.74% |
| Mar 31, 2022 | 21.36% |
| Dec 31, 2021 | 4.89% |
| Sep 30, 2021 | 25.29% |